Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10761)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2017 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Irshad M, Gupta P, Irshad K. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World J Hepatol 2017; 9(36): 1305-1314 [PMID: 29359013 DOI: 10.4254/wjh.v9.i36.1305] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i36/1305.htm |
| Number | Citing Articles |
| 1 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
|
| 2 |
Dong Lin, Venu Reddy, Hanadi Osman, Adriana Lopez, Ali Riza Koksal, Sadeq Mutlab Rhadhi, Srikanta Dash, Yucel Aydin. Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients. Cells 2021; 10(4): 790 doi: 10.3390/cells10040790
|
| 3 |
Virginia Sedeño-Monge, Francisca Sosa-Jurado, Luis Márquez-Domínguez, Paulina Cortés-Hernández, Verónica Vallejo-Ruiz, Gerardo Santos-López. Pathogens Associated with the Development of Cancer in Humans. 2024; : 71 doi: 10.1007/978-3-031-62558-9_4
|
| 4 |
Wasitha P.D. Wass Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway. Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(5): 2606 doi: 10.3390/ijms22052606
|
| 5 |
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.601710
|
| 6 |
Zuohong Ma, Yefu Liu, Zhiqiang Hao, Xiangdong Hua, Wenxin Li. DNA hypermethylation of aurora kinase A in hepatitis�C virus‑positive hepatocellular carcinoma. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10487
|
| 7 |
Aqsa Ikram, Bisma Rauff, Badr Alzahrani, Faryal Mehwish Awan, Ayesha Obaid, Anam Naz, Salik Javed Kakar, Hussnain Ahmed Janjua. Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-19854-6
|
| 8 |
Tania G. Heredia-Torres, Veronica Alvarado-Martínez, Ana R. Rincón-Sánchez, Sonia A. Lozano-Sepúlveda, Kame A. Galán-Huerta, Daniel Arellanos-Soto, Ana M. Rivas-Estilla. Hepatitis C virus NS5A and core protein induce fibrosis-related genes regulation on Huh7 cells through activation of LX2 cells. Annals of Hepatology 2024; 29(5): 101517 doi: 10.1016/j.aohep.2024.101517
|
| 9 |
Xin Liu, Yaping Lu, Liang Wang, Wei Geng, Xinyi Shi, Xiao Zhang. RF-PSSM: A Combination of Rotation Forest Algorithm and Position-Specific Scoring Matrix for Improved Prediction of Protein-Protein Interactions Between Hepatitis C Virus and Human. Big Data Mining and Analytics 2023; 6(1): 21 doi: 10.26599/BDMA.2022.9020031
|
| 10 |
Islam El-Garawani, Sobhy Hassab El-Nabi, Marwa Gadallah, Eman Abdelsameea. Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients. Immunological Investigations 2021; 50(1): 12 doi: 10.1080/08820139.2020.1722158
|
| 11 |
Tao Liu, Ya Guo, Yanxia Liao, Jinping Liu. Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1333864
|
| 12 |
Gaetano Bertino, Giulia Malaguarnera, Evelise Frazzetto, Alice Sciuto, Gaetano Inserra, Guido Nicola Zanghì, Michele Malaguarnera. Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions. World Journal of Hepatology 2018; 10(6): 448-451 doi: 10.4254/wjh.v10.i6.448
|
| 13 |
Rossana Paganoni, André Lechel, Maja Vujic Spasic. Iron at the Interface of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(8): 4097 doi: 10.3390/ijms22084097
|
| 14 |
Gesche K. Gerresheim, Elke Roeb, Audrey M. Michel, Michael Niepmann. Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells. Cells 2019; 8(11): 1410 doi: 10.3390/cells8111410
|
| 15 |
José A. Gálvez, Rafael Clavería-Gimeno, Juan J. Galano-Frutos, Javier Sancho, Adrian Velázquez-Campoy, Olga Abian, María D. Díaz-de-Villegas. Stereoselective synthesis and biological evaluation as inhibitors of hepatitis C virus RNA polymerase of GSK3082 analogues with structural diversity at the 5-position. European Journal of Medicinal Chemistry 2019; 171: 401 doi: 10.1016/j.ejmech.2019.03.019
|
| 16 |
Tania Guadalupe Heredia-Torres, Ana Rosa Rincón-Sánchez, Sonia Amelia Lozano-Sepúlveda, Kame Galan-Huerta, Daniel Arellanos-Soto, Marisela García-Hernández, Aurora de Jesús Garza-Juarez, Ana María Rivas-Estilla. Unraveling the Molecular Mechanisms Involved in HCV-Induced Carcinogenesis. Viruses 2022; 14(12): 2762 doi: 10.3390/v14122762
|
| 17 |
Shahira Amin Zayed, Nariman M. Zahran, Mervat Mamdooh Khorshied, Ashraf Omar Abdel‐Aziz, Ola Mahmoud, Shereif Ahmed Morsy, Hend Ibrahim Shousha, Tamer Mahmoud Elbaz, Mohamed Mahmoud Nabeel, Amira Ramadan Korany Harb. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma. Journal of Medical Virology 2019; 91(8): 1537 doi: 10.1002/jmv.25476
|
| 18 |
Xiaowen Li, Keke Wu, Sen Zeng, Feifan Zhao, Jindai Fan, Zhaoyao Li, Lin Yi, Hongxing Ding, Mingqiu Zhao, Shuangqi Fan, Jinding Chen. Viral Infection Modulates Mitochondrial Function. International Journal of Molecular Sciences 2021; 22(8): 4260 doi: 10.3390/ijms22084260
|
| 19 |
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 257 doi: 10.1016/B978-0-323-98806-3.00005-2
|
| 20 |
Péter Apari, Viktor Müller. Paradoxes of tumour complexity: somatic selection, vulnerability by design, or infectious aetiology?. Biological Reviews 2019; 94(3): 1075 doi: 10.1111/brv.12490
|
| 21 |
Zhen Li, Du Xiao, Xin Li, Pengchao Zhan, Jiaxiang Wang, Henghui Zhang. Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA. European Journal of Gastroenterology & Hepatology 2019; 31(7): 885 doi: 10.1097/MEG.0000000000001373
|
| 22 |
Mohamed Abu-Farha, Thangavel Alphonse Thanaraj, Mohammad G. Qaddoumi, Anwar Hashem, Jehad Abubaker, Fahd Al-Mulla. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target. International Journal of Molecular Sciences 2020; 21(10): 3544 doi: 10.3390/ijms21103544
|
| 23 |
M. Fazlalipour, H.R. Mollaei. The role of RNA viruses in human cancers. Russian Journal of Infection and Immunity 2024; 14(2): 209 doi: 10.15789/2220-7619-TRO-17585
|
| 24 |
Khetbadei Lysinia Hynniewta Hadem, Lakhon Kma, Rajeshwar N. Sharan, Arnab Sen. Handbook of Research on Advanced Phytochemicals and Plant-Based Drug Discovery. Advances in Medical Diagnosis, Treatment, and Care 2022; : 366 doi: 10.4018/978-1-6684-5129-8.ch019
|
| 25 |
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
|
| 26 |
Satoshi Miuma, Junya Miyamoto, Naota Taura, Masanori Fukushima, Ryu Sasaki, Masafumi Haraguchi, Hidetaka Shibata, Shuntaro Sato, Hisamitsu Miyaaki, Kazuhiko Nakao. Influence of Interferon-free Direct-acting Antiviral Therapy on Primary Hepatocellular Carcinoma Recurrence: A Landmark Time Analysis and Time-dependent Extended Cox Proportional Hazards Model Analysis. Internal Medicine 2020; 59(7): 901 doi: 10.2169/internalmedicine.3382-19
|
| 27 |
Nataša Pavlović, Femke Heindryckx. Targeting ER stress in the hepatic tumor microenvironment. The FEBS Journal 2022; 289(22): 7163 doi: 10.1111/febs.16145
|
| 28 |
Mariantonietta Pisaturo, Alessandra Di Fraia, Laura Occhiello, Carmine Minichini, Mario Starace, Valentina Iodice, Nunzia Farella, Maria Stanzione, Nicola Coppola. Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma. Infection and Drug Resistance 2021; : 5199 doi: 10.2147/IDR.S337647
|
| 29 |
Michael J. Diaz, Dorottya B. Kacsoh, Dhruv N. Patel, Michelle Yeagley, Monica Hsiang, George Blanck. Tumor resident, TRA anti-viral CDR3 chemical sequence motifs are associated with a better breast cancer outcome. Genes & Immunity 2023; 24(2): 92 doi: 10.1038/s41435-023-00201-2
|
| 30 |
Bilal Rah, Rafiq A Rather, Gh Rasool Bhat, Abdul Basit Baba, Ifra Mushtaq, Muzamil Farooq, Tahira Yousuf, Sadaf B Dar, Sabra Parveen, Rukhsana Hassan, Fozia Mohammad, Iqbal Qassim, Abida Bhat, Shazia Ali, Mahrukh Hamid Zargar, Dil Afroze. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.821344
|
| 31 |
Lauren Emily Fajardo, Mark Andrian Macalalad, Nyzar Mabeth Odchimar, John Christian de Guzman, Fredmoore Orosco. Computational design and validation of siRNA molecules to silence oncogenic CTNNB1 mRNA as a potential therapeutic strategy against hepatitis B/C virus-associated hepatocellular carcinoma. Pharmacia 2024; 71: 1 doi: 10.3897/pharmacia.71.e127981
|
| 32 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 33 |
Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2023; : 1 doi: 10.2174/9789815123432123010004
|
| 34 |
N. Begum Ozturk, Hoang Nhat Pham, Rama Mouhaffel, Ramzi Ibrahim, Marwan Alsaqa, Ahmet Gurakar, Behnam Saberi. A Longitudinal Analysis of Mortality Related to Chronic Viral Hepatitis and Hepatocellular Carcinoma in the United States. Viruses 2024; 16(5): 694 doi: 10.3390/v16050694
|
| 35 |
I Raafat Rowida, KA Eshra, RM El-Sharaby, RAE Eissa, SM Saied, I Amer, S El Sharawy. Apa1 (rs7975232) SNP in the vitamin D receptor is linked to hepatocellular carcinoma in hepatitis C virus cirrhosis. British Journal of Biomedical Science 2020; 77(2): 53 doi: 10.1080/09674845.2019.1680166
|
| 36 |
Isbah Ashfaq, Nadeem Sheikh, Naz Fatima, Asima Tayyeb. Inhibition of anti-inflammatory pathway through suppressors of cytokine signalling (Socs2/Socs3) in the initiation of hepatocellular carcinoma. Saudi Journal of Biological Sciences 2022; 29(8): 103348 doi: 10.1016/j.sjbs.2022.103348
|
| 37 |
Yang Zheng, Shigeru Shimamoto, Takahiro Maruno, Yuji Kobayashi, Yoshiharu Matsuura, Kazuki Kawahara, Takuya Yoshida, Tadayasu Ohkubo. N-terminal HCV core protein fragment decreases 20S proteasome activity in the presence of PA28γ. Biochemical and Biophysical Research Communications 2019; 509(2): 590 doi: 10.1016/j.bbrc.2018.12.167
|
| 38 |
Muhammad Nur Adam Hatta, Ezanee Azlina Mohamad Hanif, Siok-Fong Chin, Hui-min Neoh. Pathogens and Carcinogenesis: A Review. Biology 2021; 10(6): 533 doi: 10.3390/biology10060533
|
| 39 |
Björn L.D.M. Brücher, Ijaz S. Jamall, Obul R. Bandapalli. Chronic inflammation evoked by pathogenic stimulus during carcinogenesis. 4open 2019; 2: 8 doi: 10.1051/fopen/2018006
|
| 40 |
Shuchang Lou, Weili Sun, Yuan Wu. Biochemical overview of the recent findings on the correlation between viral hepatitis and its related hepatocellular carcinoma. Oncology and Translational Medicine 2018; 4(6): 229 doi: 10.1007/s10330-018-0305-5
|
| 41 |
Lap P. Nguyen, Tram T. T. Nguyen, Huu C. Nguyen, Hang T. Pham, Kang Min Han, Dong Hwa Choi, Eun-Mee Park, Sang Min Kang, Dongseob Tark, Yun-Sook Lim, Soon B. Hwang, J.-H. James Ou. Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly. Journal of Virology 2020; 94(19) doi: 10.1128/JVI.01306-20
|
| 42 |
Mohd Suhail, Sayed Sartaj Sohrab, Abid Qureshi, Mohd Tarique, Hany Abdel-Hafiz, Khalid Al-Ghamdi, Ishtiaq Qadri. Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma. Infection, Genetics and Evolution 2018; 60: 160 doi: 10.1016/j.meegid.2018.02.034
|
| 43 |
Mubarak A. Alamri. Bioinformatics and network pharmacology-based study to elucidate the multi-target pharmacological mechanism of the indigenous plants of Medina valley in treating HCV-related hepatocellular carcinoma. Saudi Pharmaceutical Journal 2023; 31(6): 1125 doi: 10.1016/j.jsps.2023.04.003
|
| 44 |
Maha Assem Hussein, Amal Fathy Mohammed Radwan, May Mohsen Fawzi, Laila Ahmed Rashed, Eman Hassan Ahmed Ibrahim Saad. MicroRNA 21as a novel biomarker in hepatitis C virus-related hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2022; 34(1) doi: 10.1186/s43162-022-00136-6
|
| 45 |
Rui Hao, He Lu, Yanan Guo, Qianqian Liu, Lu Wang, Yang Wang, Ailong Huang, Zeng Tu. Bioinformatics analysis of constructing a HCV-related hepatocellular carcinoma miRNA–mRNA regulation network. Medicine 2021; 100(33): e26964 doi: 10.1097/MD.0000000000026964
|
| 46 |
Giuseppa Augello, Daniele Balasus, Caterina Fusilli, Tommaso Mazza, Maria Rita Emma, Lydia Giannitrapani, Rosalia Agliastro, Melchiorre Cervello, Giuseppe Montalto. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample. OMICS: A Journal of Integrative Biology 2018; 22(4): 274 doi: 10.1089/omi.2017.0215
|
| 47 |
Livia M Villar, Cristiane A Villela-Nogueira, Allan P da Silva, Letícia P Scalioni. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.77387
|
| 48 |
Prajjalendra Barooah, Snigdha Saikia, Manas Jyoti Kalita, Rituraj Bharadwaj, Preeti Sarmah, Mallika Bhattacharyya, Bhabadev Goswami, Subhash Medhi. IL-10 Polymorphisms and Haplotypes Predict Susceptibility to Hepatocellular Carcinoma Occurrence in Patients with Hepatitis C Virus Infection from Northeast India. Viral Immunology 2020; 33(6): 457 doi: 10.1089/vim.2019.0170
|
| 49 |
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
|
| 50 |
Nur Signa Aini Gumilas, Irianiwati Widodo, Neneng Ratnasari, Didik Setyo Heriyanto. Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis. Non-coding RNA Research 2022; 7(1): 34 doi: 10.1016/j.ncrna.2022.01.004
|
| 51 |
Eman A. E. Badr, Elshaymaa I. Elmongy, Rasha Galal Mostafa, Ibrahim El-Tantawy El-Sayed, Abd El-Naser Abd El-Ati Gad Allah, Asmaa Khairy Ahmed, Yasser A. S. Elghobashy. The Role of LINC01564, RAMS11, CBX4 and TOP2A in Hepatocellular Carcinoma. Biomedicines 2022; 11(1): 56 doi: 10.3390/biomedicines11010056
|
| 52 |
Maria I. Poole, Inmaculada Sorribes, Harsh Vardhan Jain. Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis. Mathematical Biosciences 2018; 306: 186 doi: 10.1016/j.mbs.2018.10.003
|
| 53 |
Michael K. Turgeon, Shimul A. Shah, Aaron M. Delman, Benjamin V. Tran, Vatche G. Agopian, Joel P. Wedd, Joseph F. Magliocca, Ahyoung Kim, Andrew Cameron, Ali Olyaei, Susan L. Orloff, Matthew P. Anderson, Chandrashekhar A. Kubal, Robert M. Cannon, Jayme E. Locke, Mary A. Simpson, Mohamed E. Akoad, Chelsey P. Wongjirad, Juliet Emamaullee, Amika Moro, Federico Aucejo, Cyrus A. Feizpour, Parsia A. Vagefi, Mindie H. Nguyen, Carlos O. Esquivel, Kiran Dhanireddy, Vijay Subramanian, Alejandro Chavarriaga, Marwan M. Kazimi, Maia S. Anderson, Christopher J. Sonnenday, Steven C. Kim, David P. Foley, Marwan Abdouljoud, Reena J. Salgia, Dimitrios Moris, Debra L. Sudan, Swaytha R. Ganesh, Abhinav Humar, Majella Doyle, William C. Chapman, Shishir K. Maithel. Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation. Annals of Surgery 2021; 274(4): 613 doi: 10.1097/SLA.0000000000005070
|
| 54 |
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection. Viral Immunology 2019; 32(3): 112 doi: 10.1089/vim.2018.0124
|
| 55 |
Mousumi Khatun, Ranjit Ray, Ratna B. Ray. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 103 doi: 10.1016/bs.acr.2020.10.003
|
| 56 |
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences 2022; 23(21): 13612 doi: 10.3390/ijms232113612
|